Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Sam Fazeli

๐Ÿ‘ค Speaker
634 total appearances

Appearances Over Time

Podcast Appearances

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

We've just conducted, it took us a long time to get this organized, a 600 plus C-suite survey for AI, which is published today.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

10 or 12 questions general across the 600 folks and companies from about 1,000 individuals upwards, employees.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

And then we went and segmented the companies into 10 buckets, one of which was pharmaceuticals.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

So we have about 50 respondents.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

And we will come back to that.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

I'm going to do a webinar of our own with my colleague with our findings from what they said about the impact of AI that they are looking at within their companies.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

But one of the key themes that seems to keep coming up is that the U.S.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

seems to have pretty much, let's put China aside now because they have a different strategy that they're pursuing with NVIDIA, with the chat GPT, with OpenAI, with Anthropic, etc.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

They seem to have sewn up the world of AI models, except for one company, which doesn't come up enough in my view, which is Mistral.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

There is a model that's based out of France that is, I think a lot of people are using it and having very positive reaction to it, except that all the noise and news we hear is about OpenAI and Anthropic and all these companies and Gemini, et cetera.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

So talk to this point to me, please.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

When you look at your portfolio,

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

Do you find France specifically a strong candidate for generating these new tech ideas?

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

Do you find Europe particularly positive?

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

Are there pockets where you go, hey, we're doing really well here and it's under the radar, which is great for me to hear.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

Or are you ending up doing 80% of your investments in the U.S.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

How long have you been doing this?

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

Seven years.

Vanguards of Health Care by Bloomberg Intelligence
Sofinnova Partners Stays Optimistic on Biotech's Future

And it's based on an LLM?